Biogen Announces $5.6 Billion Takeover of Apellis, Expanding Rare‑Disease Portfolio
🎧 Listen:By Connor Hart | March 31, 2026Biogen’s $5.6 B Acquisition of Apellis Aims to Supercharge Rare‑Disease Innovation Deal value of ...
Tag: Biotech Acquisition
Gilead Bets $2.2 Billion on Ouro Medicines to Expand Autoimmune Pipeline
🎧 Listen:By Kelly Cloonan | March 23, 2026Gilead Sciences to Spend Up to $2.18 Billion for Ouro Medicines in Autoimmune ...